Two risk factors for hypozincemia in diabetic β-thalassemia patients: Hepatitis C and deferasirox.

Hadi Darvishi-KhezriHossein KaramiMohammad NaderisorkiMobin GhazaieanMehrnoush KosaryanAmir Mosanejad-GalchaliAily AliasgharianHasan Karami

Published in: PloS one (2024)

In light of this study, as well as hepatitis C, using DFX and antacids is associated with a high risk of hypozincemia amid diabetic β-thalassemia cases. However, upward bias should be taken into consideration.

Keyphrases

end stage renal disease
type diabetes
ejection fraction
newly diagnosed
chronic kidney disease
wound healing
peritoneal dialysis
sickle cell disease